Sign in

CIK 0001644963

  • Non-accelerated filer
  • Smaller reporting company

AVENUE THERAPEUTICS, INC.

Sign in to watch
Ticker
ATXI
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474113275
Phone
+1 781-652-4500
Business address
1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
  1. 4 Open-market buy Director bought 2,000 shares at $5.11 ($10,220)
  2. 4 Open-market buy Director bought 5,000 shares at $5.46 ($27,300)
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market buy Director bought 8,850 shares at an average $5.88 ($52,045)
  6. 4 Open-market buy Director bought 650 shares at $5.91 ($3,842)
  7. 4 Open-market buy Director bought 10,000 shares at an average $5.90 ($58,999)
  8. 4 Open-market buy Director bought 15,000 shares at an average $5.24 ($78,554)
  9. 4 Gift VP Finance & Corp. Controller gave 30,000 shares (gift)
  10. 4 Gift President, CEO gave 250,000 shares (gift)
  11. 4 Gift Director gave 14,663 shares (gift)
  12. 4 Gift Director gave 14,663 shares (gift)
  13. 4 Gift Director gave 14,663 shares (gift)
  14. 4 Gift Interim Chief Medical Officer gave 10,000 shares (gift)
  15. 4 Gift Director gave 14,663 shares (gift)
  16. 4 Gift Director gave 14,663 shares (gift)
  17. 4 Gift Director gave 14,663 shares (gift)
  18. 4 Grant or award VP Finance & Corp. Controller acquired 1,351 shares (grant or award)
  19. 4 Grant or award President, CEO acquired 5,000 shares (grant or award)
  20. 4/A Open-market buy Director bought 50,000 shares at an average $4.28 ($214,143)

Page 4 of 5 · 96 filings